Introduction
Apolipoprotein H (APOH), also known as Beta-2-glycoprotein I, is a multifunctional protein with a high affinity for negatively charged substances such as heparin, phospholipids, and dextran sulfate. One of its key roles is inhibiting the intrinsic pathway of blood coagulation by binding to phospholipids exposed on damaged cell surfaces. APOH is primarily synthesized in the liver and secreted into the bloodstream.
Description
This product consists of human APOH purified from human plasma. It has a molecular weight of 50 kDa and an isoelectric point (pI) ranging from 5.6 to 6.4. As a prominent phospholipid-binding protein, APOH serves as a crucial marker in diagnosing antiphospholipid syndrome (APS). Compared to anti-cardiolipin antibodies, APOH demonstrates superior specificity, and its presence exhibits a stronger correlation with thrombotic events.
Physical Appearance
This product is a sterile, filtered, white powder that has been lyophilized (freeze-dried).
Formulation
The lyophilization process was carried out using a 0.02M ammonium bicarbonate (NH4HCO3) solution.
Solubility
To reconstitute the lyophilized APOH powder, it is recommended to use a phosphate buffer solution with a pH greater than 7.0 and containing 0.15M sodium chloride (NaCl).
Stability
While human APOH exhibits stability at room temperature for a period of 3 weeks, it is advisable to store the product between 2-8°C to maintain optimal stability.
Purity
The purity of this product is guaranteed to be greater than 96.0%.
Human Virus Test
The starting material used for production has undergone rigorous testing and has been confirmed negative for HIV I & II antibodies, Hepatitis B surface antigen, and Hepatitis C antibodies.
Synonyms
Beta-2-glycoprotein 1, Beta-2-glycoprotein I, Apolipoprotein H, Apo-H, B2GPI, Beta(2)GPI, Activated protein C-binding protein, APC inhibitor, Anticardiolipin cofactor, APOH, B2G1, BG, B2GP-1, B2 Glycoprotein-I.